by investoropportunity | Sep 22, 2024 | Company Research, Energy, Home Page Articles of Insight, Mining, Technology
A world class hydrogen asset in the making. The level of interest from large industry players now following QI Materials’ hydrogen exploration efforts is significant. Chances are QIMC will not exist in a year or so as with every positive news release it increasingly...
by investoropportunity | Apr 30, 2024 | Company Research, Home Page Articles of Insight
According to the Centers for Medicare and Medicaid Services, Americans spent $4.4 trillion on healthcare in 2022, ~$3 trillion of this spending flowed through health insurance companies. Healthcare spending is forecast to top $7 trillion in 2031. What makes Oscar...
by investoropportunity | Mar 15, 2023 | Company Research, Health, Home Page Articles of Insight, Technology, Uncategorized
PharmAla is the first for-profit company to synthesize clinical-grade (GMP) MDMA and make it available for sale to both researchers and qualified patients. PharmAla will increasingly develop a target on its back for acquisition and we expect a rise in marketcap via...
by investoropportunity | Jan 21, 2023 | Health, Home Page Articles of Insight, Technology
Editas Medicine currently trades at an enterprise value of just $561 million, but its IP portfolio alone is worth billions. This stock traded at over $80/share 2 years ago and is now under $9/share, however the reasons for buying then are just as strong now. It’s...
by investoropportunity | Nov 18, 2022 | Company Research, Health, Home Page Articles of Insight, Technology
Vicarious Surgical Robotic System was added to Time Magazine’s list for the ‘Best Inventions of 2022’ — for reference; Apple’s iPhone was featured by Time in 2007 Best Inventions — NYSE: RBOT has moon-shot potential. Vicarious Surgical...
by investoropportunity | Oct 11, 2022 | Home Page Articles of Insight, Industry & Services, Uncategorized, Utilities Telecom Networks
AWK is a steadily growing cash-cow via regular utility rate increases, new contracts, and annual targeted acquisitions. AWK is also steady dividend payer; today yielding 2% — each year AWK raises the dividends per share, meaning greater compound returns in the...
Recent Comments